Methimazole NDC 62135-205

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-205Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0205Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-205-01	62135020501	100 TABLET in 1 BOTTLE (62135-205-01)Marketed from Nov 4, 2021
62135-205-05	62135020505	500 TABLET in 1 BOTTLE (62135-205-05)Marketed from Nov 4, 2021
62135-205-18	62135020518	180 TABLET in 1 BOTTLE (62135-205-18)Marketed from Nov 4, 2021
62135-205-30	62135020530	30 TABLET in 1 BOTTLE (62135-205-30)Marketed from Nov 4, 2021
62135-205-90	62135020590	90 TABLET in 1 BOTTLE (62135-205-90)Marketed from Nov 4, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methimazole
Generic name (nonproprietary): methimazole
Active ingredients: Methimazole — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040411
Marketing start: Mar 27, 2001
Listing expires: Dec 31, 2027
Other FDA classes: Thyroid Hormone Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 62135-205_4cb57dfc-1ebf-8510-e063-6294a90a31fcSPL ID 4cb57dfc-1ebf-8510-e063-6294a90a31fcSPL set ID 5b25e346-11b6-44ed-89f9-ab927232ac19RxCUI 197941, 197942UNII 554Z48XN5EUPC 0362135206307, 0362135205904, 0362135205010, 0362135205300, 0362135206901, 0362135205188, 0362135205058, 0362135206185, 0362135206017
Pharmacologic class: Thyroid Hormone Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135020501 followed by a unit qualifier and the quantity

Package 62135-0205-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 10, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methimazole tablets, USP are indicated: In patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040411

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040411
Product	Strength	Form · route	Labeler	Product NDC
Methimazole	Methimazole 10 mg/1	TabletOral	Chartwell RX, LLC	62135-206